Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7543334

Concept 2023-06-01 to
2023-08-31
2023-03-01 to
2023-08-31
As at
2023-08-31
As at
2023-02-28
2022-03-01 to
2023-02-28
As at
2022-08-31
2022-06-01 to
2022-08-31
2022-03-01 to
2022-08-31
Key financial data of reporting company
Business results of reporting company
Net sales
66,977,000,000 JPY
128,330,000,000 JPY
59,619,000,000 JPY
Ordinary profit (loss)
11,640,000,000 JPY
16,051,000,000 JPY
8,870,000,000 JPY
Net assets
275,108,000,000 JPY
258,408,000,000 JPY
266,277,000,000 JPY
Total assets
344,300,000,000 JPY
313,917,000,000 JPY
327,897,000,000 JPY
Basic earnings (loss) per share
56.25
108.34
148.01
61.11
81.58
Diluted earnings per share
108.23
147.88
81.51
Equity-to-asset ratio
0.792 xbrli:pure
0.816 xbrli:pure
0.805 xbrli:pure
Net cash provided by (used in) operating activities
7,851,000,000 JPY
12,727,000,000 JPY
8,162,000,000 JPY
Net cash provided by (used in) investing activities
10,443,000,000 JPY
-23,868,000,000 JPY
-17,928,000,000 JPY
Net cash provided by (used in) financing activities
-4,841,000,000 JPY
-14,687,000,000 JPY
-3,641,000,000 JPY
Cash and cash equivalents
81,186,000,000 JPY
65,424,000,000 JPY
78,771,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.